General Recommendation: Clarity Pharmaceuticals Ltd
Clarity Pharmaceuticals Ltd (ASX: CU6)
Target: 7.04
Stop Loss: 4.3
Clarity Pharmaceuticals Ltd. is a clinical stage radiopharmaceutical company. It engages in research and development and clinical stage evaluation of its portfolio of novel radiopharmaceuticals products. The company was founded by Matthew Harris on April 8, 2010 and is headquartered in Eveleigh, Australia.
Note: The closing must be tracked on weekly basis i.e you should exit the position only if the stock closes below the stoploss level.
Disclaimer: Sanjeev Kaushik is an Authorised Representative (No. 001303793) of MF & CO Asset Management Pty Ltd (AFSL 520442). This content is not personal financial advice that takes into account your objectives, financial situation and needs. You should consider the appropriateness of the general information presented herein having regard to your own circumstances prior to making any investment decisions.
This video contains paid promotional content sponsored by Moomoo Securities Australia Ltd (ABN 51 095 920 648; AFSL 224663; "Moomoo") for promoting Moomoo's products and services. All investments carry risks. Options trading involves substantial capital risks and may not be suitable for everyone. Refer to full Rewards T&Cs, Moomoo's FSG, US Options PDS and Target Market Determination through link in descriptions before deciding to use Moomoo's services.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
Australia based stockbroker and investment adviser.
29Followers
0Following
52Visitors
Follow